Long-term follow-up of preoperative pelvic radiation therapy and concomitant boost irradiation in locally advanced rectal cancer patients: A multi-institutional phase II study (KROG 04-01)

International Journal of Radiation Oncology Biology Physics

Volumn 84, Issue 4, 2012, Pages 955-961

  Lee, Jong Hoon ^a,e   Kim, Dae Yong ^b   Nam, Taek Keun ^c   Yoon, Sei Chul ^a   Lee, Doo Seok ^d   Park, Ji Won ^b   Oh, Jae Hwan ^b   Chang, Hee Jin ^b   Yoon, Mee Sun ^c   Jeong, Jae Uk ^c   Jang, Hong Seok ^a  

^a The Catholic University of Korea   (South Korea)

^b National Cancer Center   (South Korea)

^c Chonnam National University Medical School   (South Korea)

^d Daehang Hospital   (South Korea)

^e The Catholic University of Korea   (South Korea)

Author keywords

Chemoradiation therapy; Prognostic factor; Rectal cancer; Response; Small field

Indexed keywords

CHEMORADIOTHERAPY; DISEASES; IRRADIATION; MULTIVARIANT ANALYSIS; PATHOLOGY; PATIENT TREATMENT; RADIATION; TOXICITY; TUMORS;

CHEMORADIATION THERAPIES; PROGNOSTIC FACTORS; RECTAL CANCER; RESPONSE; SMALL FIELD;

RADIOTHERAPY;

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; ANTINEOPLASTIC ANTIMETABOLITE;

ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANEMIA; ARTICLE; BLADDER DISEASE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHRONIC DIARRHEA; CHRONIC TOXICITY; CLINICAL FEATURE; CYSTITIS; DERMATITIS; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PELVIS; PELVIS ABSCESS; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PELVIC RADIATION THERAPY; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROCTITIS; PROSPECTIVE STUDY; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RADIATION SAFETY; RECTUM ANTERIOR RESECTION; RECTUM CANCER; REOPERATION; SMALL INTESTINE OBSTRUCTION; SURVIVAL RATE; THROMBOCYTOPENIA; TREATMENT DURATION; ADJUVANT THERAPY; DRUG ADMINISTRATION; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PREOPERATIVE CARE; RECTUM TUMOR; REMISSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CHEMORADIOTHERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; PELVIS; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOTHERAPY, ADJUVANT; RECTAL NEOPLASMS; REMISSION INDUCTION; SURVIVAL RATE;

EID: 84872012829     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2012.01.045     Document Type: Article

References (20)

1. Sauer R, Becker H, Hohenberger W, et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351:1731-1740.
2. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemo-radiation for rectal cancer. Br J Surg 2006; 93:1215-1223.
3. Rodel C, Martus P, Papadoupolos T, et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005; 23:8688-8696.
4. Kim TH, Chang HJ, Kim DY, et al. Pathologic nodal classification is the most discriminating prognostic factor for disease-free survival in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection. Int J Radiat Oncol Biol Phys 2010; 77: 1158-1165.
5. Lee JH, Kim SH, Kim JG, et al. Preoperative chemoradiotherapy (CRT) followed by laparoscopic surgery for rectal cancer: Predictors of the tumor response and the long-term oncologic outcomes. Int J Radiat Oncol Biol Phys 2011; 82:431-438.
6. Fakih MG, Bullarddunn K, Yang GY, et al. Phase II study of weekly intravenous oxaliplatin combined with oral daily capecitabine and radiotherapy with biologic correlates in neoadjuvant treatment of rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 2008; 72: 650-657.
7. Hong YS, Kim DY, Lim SB, et al. Preoperative chemoradiation with irinotecan and capecitabine in patients with locally advanced resect-able rectal cancer: Long-term results of a Phase II study. Int J Radiat Oncol Biol Phys 2011; 79:1171-1178.
8. Gérard JP, Azria D, Gourgou-Bourgade S, et al. Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: Results of the phase III trial ACCORD 12/0405-Prodige 2. J Clin Oncol 2010; 28:1638-1644.
9. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000; 48:7-16.
10. Kim DY, Kim TH, Jung KH, et al. Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: A multi-institutional phase II study (KROG 04-01). Dis Colon Rectum 2006; 49:1684-1691.
11. Dworak O, Keilholz L, Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997; 12:19-23.
12. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual. 7th ed. New York: Springer-Verlag; 2009. p. 143-173.
13. Sauer R, Fietkau R, Wittekind C, et al. Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: A progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 2001; 177:173-181.
14. Gérard JP, Conroy T, Bonnetain F, et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006; 24: 4620-4625.
15. Yoon SM, Kim DY, Kim TH, et al. Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2007; 69:1167-1172.
16. Mohiuddin M, Winter K, Mitchell E, et al. Randomized phase II study of neoadjuvant combined-modality chemoradiation for distal rectal cancer: Radiation Therapy Oncology Group Trial 0012. J Clin Oncol 2006; 24:650-655.
17. Movsas B, Diratzouian H, Hanlon A, et al. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. Am J Clin Oncol 2006; 29: 435-441.
18. Marsh Rde W, George TJ, Siddiqui T, et al. A phase II trial of neo-adjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer. Am J Clin Oncol 2010; 33:251-256.
19. Li M, Li JY, Zhao AL, et al. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas. Oncology 2007; 73:52-57.
20. Lee JH, Jang HS, Kim JG, et al. Lymphovascular invasion is a significant prognosticator in rectal cancer patients who receive preoperative chemoradiotherapy followed by total mesorectal excision. Ann Surg Oncol 2012; 19:1213-1221.